Cardiff Oncology, Inc. (CRDF) vs ProMIS Neurosciences, Inc. (PMN)
A side-by-side comparison of Cardiff Oncology, Inc. and ProMIS Neurosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CRDF
Cardiff Oncology, Inc.
$1.09HealthcareDelayed quote: Oct 6, 2026, 12:55 PM EDT
PMN
ProMIS Neurosciences, Inc.
$9.32HealthcareDelayed quote: Oct 6, 2026, 12:49 PM EDT
Total return — CRDF vs PMN
growth of $100 · dividends reinvested · last 10yCRDF -99.6% (-43.1%/yr)PMN -92.2% (-22.5%/yr)PMN compounded faster over this window
Log scale — wide-divergence pair
CRDF PMN
CRDF vs PMN: by the numbers
- •CRDF is the larger company ($84M vs $84M market cap).
- •Both run net losses; PMN's is the smaller (0.00% vs -7884.06% net margin).
Metrics side by side
Valuation
| Metric | CRDF | PMN |
|---|---|---|
| P/S ratio | 164.62 | N/A |
| P/B ratio | 3.15 | 1.69 |
Profitability
| Metric | CRDF | PMN |
|---|---|---|
| Gross margin | 100.00% | 0.00% |
| Operating margin | -8256.32% | 0.00% |
| Net margin | -7884.06% | 0.00% |
| ROE | -150.95% | -85.48% |
| ROIC | -159.30% | -87.79% |
Growth (annualized)
| Metric | CRDF | PMN |
|---|---|---|
| Revenue CAGR (5Y) | 5.15% | N/A |
| Total return CAGR (5Y) | -30.36% | -47.05% |
Frequently asked
- How have CRDF and PMN total returns compared?
- Over the past 10 years, CRDF delivered -43.20% and PMN delivered -22.51% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.